Multiplikator Forward P/S: PROCEPT BioRobotics Corporation (PRCT)
Ambitious management is driving rapid market capture for PROCEPT BioRobotics (PRCT), as confirmed by an upward trend where the current value equals 3.80. The forward P/S ratio reflects investor optimism. Growth is based on unique aquablation in the US and steady revenue from the sale of consumables for robotic consoles for urologists.
Ringkesan rincian data analitis Procept (PRCT)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal PROCEPT BioRobotics|PRCT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal PROCEPT BioRobotics|PRCT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Procept|PRCT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan PROCEPT BioRobotics|Rasio cepet procept-biorobotics.com
- rincian asil keuangan lan kelipatan valuasi:
PRCT - Penghasilan resik perusahaan|Bathi sing dikarepake PROCEPT BioRobotics|PRCT - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi PROCEPT BioRobotics Inc|PRCT - Pangali PEG|Pangali EV/EBITDA Procept|PRCT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan PROCEPT BioRobotics|PRCT - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan procept-biorobotics.com|PRCT - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep PROCEPT BioRobotics
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:PRCT (PROCEPT BioRobotics Corporation)
PROCEPT BioRobotics revenue is based on the sale of AquaBeam systems and consumables, making the forward P/S multiple a critical tool for assessing expected capitalization relative to future sales. The current value of 3.80 allows investors to filter out market noise and determine whether the revenue premium is justified given the global expansion rates of medical equipment.
Karo sapa PROCEPT BioRobotics saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator Forward P/S|InMode Ltd (INMD) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S PMI|Multiplikator forward rega marang pendapatan Surmodics Inc. SRDX|Multiplikator Forward P/S SENS (Senseonics Holdings)|Multiplikator Forward P/S neuropace.com NPCE|TCMD - Rasio rega marang prakiraan pendapatan|SNWV: Rasio rega marang prakiraan pendapatan|OM (Outset) - Multiplikator forward rega marang pendapatan|Electromed - Rega forward marang dodolan|LNSR (LENSAR, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep avitamedical.com RCEL|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|beyondair.net (XAIR) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan PFSA (profusa.com)|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|GCTK: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD - Multiplikator forward rega marang pendapatan|TransEnterix - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Avinger Inc.|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CUTR (Cutera Inc)|Multiplikator forward rega marang pendapatan KNW|NARI (inarimedical.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
